Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.845
-0.115 (-5.87%)
Oct 10, 2025, 1:24 PM EDT - Market open
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $58.04 million as of October 10, 2025. Its market cap has decreased by -73.94% in one year.
Market Cap
58.04M
Enterprise Value
-72.51M
1-Year Change
-73.94%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $58.04M, a decrease of -75.32%. That is a compound annual growth rate of -38.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 61.65M | -67.11% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |